ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,811,388 | +4.2% | 1,659,923 | -0.1% | 0.00% | 0.0% |
Q2 2023 | $20,936,047 | -3.9% | 1,661,591 | -0.4% | 0.00% | 0.0% |
Q1 2023 | $21,779,536 | -26.8% | 1,668,930 | -1.1% | 0.00% | -33.3% |
Q4 2022 | $29,772,227 | +14.5% | 1,687,768 | -1.1% | 0.01% | 0.0% |
Q3 2022 | $25,995,000 | +0.2% | 1,706,813 | -2.4% | 0.01% | 0.0% |
Q2 2022 | $25,933,000 | -38.0% | 1,748,641 | -5.9% | 0.01% | -14.3% |
Q1 2022 | $41,833,000 | +19.1% | 1,857,577 | -2.4% | 0.01% | +16.7% |
Q4 2021 | $35,115,000 | +36.8% | 1,903,249 | -0.9% | 0.01% | +20.0% |
Q3 2021 | $25,678,000 | -34.6% | 1,920,546 | -9.4% | 0.01% | -28.6% |
Q2 2021 | $39,237,000 | +15.7% | 2,119,743 | -6.2% | 0.01% | +16.7% |
Q1 2021 | $33,916,000 | -19.3% | 2,258,817 | -22.4% | 0.01% | -25.0% |
Q4 2020 | $42,022,000 | +73.0% | 2,910,142 | -2.5% | 0.01% | +60.0% |
Q3 2020 | $24,284,000 | +18.0% | 2,983,300 | -1.8% | 0.01% | 0.0% |
Q2 2020 | $20,576,000 | -0.6% | 3,039,391 | +3.3% | 0.01% | -16.7% |
Q1 2020 | $20,708,000 | -28.6% | 2,941,487 | -0.5% | 0.01% | 0.0% |
Q4 2019 | $29,022,000 | -12.6% | 2,956,880 | -2.2% | 0.01% | -25.0% |
Q3 2019 | $33,189,000 | -1.8% | 3,022,715 | +4.0% | 0.01% | 0.0% |
Q2 2019 | $33,804,000 | +33.7% | 2,906,636 | +9.7% | 0.01% | +33.3% |
Q1 2019 | $25,278,000 | -0.9% | 2,649,744 | +0.2% | 0.01% | -14.3% |
Q4 2018 | $25,498,000 | -32.5% | 2,645,007 | -0.2% | 0.01% | -22.2% |
Q3 2018 | $37,785,000 | +14.7% | 2,651,520 | -3.4% | 0.01% | +12.5% |
Q2 2018 | $32,945,000 | -8.5% | 2,745,440 | -5.9% | 0.01% | -11.1% |
Q1 2018 | $36,021,000 | -15.6% | 2,916,698 | -0.6% | 0.01% | -18.2% |
Q4 2017 | $42,691,000 | -2.6% | 2,934,089 | -4.7% | 0.01% | 0.0% |
Q3 2017 | $43,809,000 | +17.2% | 3,078,638 | +5.1% | 0.01% | +10.0% |
Q2 2017 | $37,391,000 | +71.9% | 2,930,365 | +70.8% | 0.01% | +66.7% |
Q1 2017 | $21,750,000 | +26.9% | 1,715,345 | +2.2% | 0.01% | +20.0% |
Q4 2016 | $17,144,000 | -18.0% | 1,679,137 | +5.8% | 0.01% | -28.6% |
Q3 2016 | $20,909,000 | +6.3% | 1,587,604 | +2.5% | 0.01% | +16.7% |
Q2 2016 | $19,665,000 | -3.2% | 1,548,433 | +0.7% | 0.01% | -14.3% |
Q1 2016 | $20,309,000 | -12.8% | 1,537,398 | +1.5% | 0.01% | -12.5% |
Q4 2015 | $23,288,000 | +20.0% | 1,514,210 | -3.3% | 0.01% | +33.3% |
Q3 2015 | $19,410,000 | -2.1% | 1,565,356 | +8.0% | 0.01% | 0.0% |
Q2 2015 | $19,833,000 | +22.5% | 1,449,777 | +7.1% | 0.01% | +20.0% |
Q1 2015 | $16,192,000 | -9.8% | 1,353,886 | -3.7% | 0.01% | 0.0% |
Q4 2014 | $17,953,000 | -1.8% | 1,405,965 | +3.1% | 0.01% | -16.7% |
Q3 2014 | $18,291,000 | -17.1% | 1,363,480 | -0.8% | 0.01% | -14.3% |
Q2 2014 | $22,065,000 | -7.3% | 1,374,773 | +4.2% | 0.01% | 0.0% |
Q1 2014 | $23,799,000 | +20.5% | 1,319,992 | +3.3% | 0.01% | +16.7% |
Q4 2013 | $19,755,000 | +7.4% | 1,277,787 | +3.3% | 0.01% | 0.0% |
Q3 2013 | $18,401,000 | +5.3% | 1,237,437 | -8.4% | 0.01% | 0.0% |
Q2 2013 | $17,473,000 | – | 1,350,362 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |